Impact of Home Medicines Review on medication regimen complexity

Abstract Background Previous studies on pharmacist‐led Home Medicines Review (HMR) have demonstrated positive associations of HMR and clinical outcomes. However, little is known about their impact on medication regimen complexity. Aim Investigate the impact of pharmacist‐led HMRs on simplifying medication regimen complexity using the Medication Regimen Complexity Index (MRCI). Method A retrospective cohort study of 196 general practitioners (GPs) initiated HMRs, conducted over a period of 2 years (2020–2022) using two credentialed pharmacists in New South Wales, Australia. MRCI was used to measure the complexity at two separate time points, at baseline and following pharmacists' recommendations (assuming the GPs accepted all of the pharmacists' recommendations provided during the HMRs). The Wilcoxon signed‐rank test was used to determine the difference between the scores at baseline and after HMR. Ethical approval was granted by the University of Sydney Human Research Ethics Committee (Reference no: 2022/584) and the study conforms to the Australian National statement on the ethical conduct in human research . Results During the HMR service, pharmacists made a total of 792 recommendations (mean ± standard deviation [4.04 ± 2.3] per HMR), among which dosage and frequency adjustment, laboratory monitoring, and therapeutic monitoring were the most common, collectively accounting for almost half of the recommendations. The median MRCI score at baseline was 28.5 (interquartile range [IQR] 21.5–37.6) and following pharmacists' recommendations was 29 (IQR 21.9–37.1). The difference between the baseline and post‐HMR scores was not statistically significant. Conclusion Our study demonstrates the lack of significant reductions in medication complexity following HMRs as measured by the MRCI. However, these results need to be interpreted with caution as not all interactions with patients lead to a change in the MRCI score. Comprehensive examination of individual medication changes may provide more meaningful and clinically relevant inferences.

Authors

Institutions

Publication Details

Journal
Journal of Pharmacy Practice and Research
Published
2024-11-25
DOI
https://doi.org/10.1002/jppr.1945
Citations
2
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.69

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Home Medicines Review on medication regimen complexity

Shrey Seth, Ronald Lynel Castelino, Sathvik Belagodu Sridhar, Girish Thunga et al.
2 citations
Journal of Pharmacy Practice and Research
Pharmaceutical Practices and Patient Outcomes
0.69
article

Impact of Home Medicines Review on medication regimen complexity

Shrey Seth, Ronald Lynel Castelino, Sathvik Belagodu Sridhar, Girish Thunga, Lipin Lukose, Wubshet Tesfaye
article en
2 citations

Abstract

Abstract Background Previous studies on pharmacist‐led Home Medicines Review (HMR) have demonstrated positive associations of HMR and clinical outcomes. However, little is known about their impact on medication regimen complexity. Aim Investigate the impact of pharmacist‐led HMRs on simplifying medication regimen complexity using the Medication Regimen Complexity Index (MRCI). Method A retrospective cohort study of 196 general practitioners (GPs) initiated HMRs, conducted over a period of 2 years (2020–2022) using two credentialed pharmacists in New South Wales, Australia. MRCI was used to measure the complexity at two separate time points, at baseline and following pharmacists' recommendations (assuming the GPs accepted all of the pharmacists' recommendations provided during the HMRs). The Wilcoxon signed‐rank test was used to determine the difference between the scores at baseline and after HMR. Ethical approval was granted by the University of Sydney Human Research Ethics Committee (Reference no: 2022/584) and the study conforms to the Australian National statement on the ethical conduct in human research . Results During the HMR service, pharmacists made a total of 792 recommendations (mean ± standard deviation [4.04 ± 2.3] per HMR), among which dosage and frequency adjustment, laboratory monitoring, and therapeutic monitoring were the most common, collectively accounting for almost half of the recommendations. The median MRCI score at baseline was 28.5 (interquartile range [IQR] 21.5–37.6) and following pharmacists' recommendations was 29 (IQR 21.9–37.1). The difference between the baseline and post‐HMR scores was not statistically significant. Conclusion Our study demonstrates the lack of significant reductions in medication complexity following HMRs as measured by the MRCI. However, these results need to be interpreted with caution as not all interactions with patients lead to a change in the MRCI score. Comprehensive examination of individual medication changes may provide more meaningful and clinically relevant inferences.

Journal of Pharmacy Practice and ResearchVol. 55(2)
The University of Sydney (AU), Manipal Academy of Higher Education (IN), Blacktown & Mount Druitt Hospital (AU), Ras al-Khaimah Medical and Health Sciences University (AE)
University of Sydney, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education
Openalex Percentile: Top 29%
Pharmaceutical Practices and Patient Outcomes
0.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.